THE HEART OF THE MATTER

Neovasc is a specialty medical device company that develops, manufactures and markets products for the cardiovascular marketplace. The company is focused on the development of minimally-invasive treatments for two of the most vexing challenges in cardiology today; refractory angina and mitral regurgitation. We believe there is tremendous potential in addressing these hard-to-treat conditions.

Neovasc is a publicly-traded company on both the NASDAQ and Toronto stock exchanges.

 

NVCN

NASDAQ

TORONTO (TSX)

Neovasc@

2022 Sidoti & Co. Summer Small Cap
Virtual Investor Conference
1:45 p.m. ET.
Wednesday, June 15, 2022

register here >

Q2 2022 Earnings Call

8.11.2022 | 4:30p.m. ET

1-877-407-9208 | Int’l: 1-201-493-6784
Conference ID: 13730925

webcast registration >